A tool to estimate survival of elderly patients presenting with metastatic epidural spinal cord compression (MESCC) from cancer of unknown primary

Dirk Rades, Antonio J. Conde-Moreno, Raquel Garcia, Theo Veninga, Steven E. Schild

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Aim: Cancers of unknown primary (CUP) account for about 10% in elderly patients with MESCC. Immediate treatment is indicated. Personalizing treatment for MESCC requires for clear understanding of the patients' survival prognosis. In this case, a tool for estimating survival would be valuable. Patients and Methods: In 104 elderly CUP patients, nine factors were investigated: age, gender, performance score, number of affected vertebrae, ability to walk at presentation for radiotherapy, additional bone metastases, visceral metastases, time developing motor weakness, radiotherapy program. Results: In multivariate analysis, the ability to walk (p=0.011) and visceral metastases (p

Original languageEnglish (US)
Pages (from-to)6219-6222
Number of pages4
JournalAnticancer Research
Volume35
Issue number11
StatePublished - Nov 1 2015

Fingerprint

Spinal Cord Compression
Survival
Neoplasm Metastasis
Neoplasms
Radiotherapy
Spine
Multivariate Analysis
Bone and Bones
Therapeutics

Keywords

  • Cancer of unknown primary
  • Elderly
  • MESCC
  • Radiation therapy
  • Survival tool

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

A tool to estimate survival of elderly patients presenting with metastatic epidural spinal cord compression (MESCC) from cancer of unknown primary. / Rades, Dirk; Conde-Moreno, Antonio J.; Garcia, Raquel; Veninga, Theo; Schild, Steven E.

In: Anticancer Research, Vol. 35, No. 11, 01.11.2015, p. 6219-6222.

Research output: Contribution to journalArticle

Rades, Dirk ; Conde-Moreno, Antonio J. ; Garcia, Raquel ; Veninga, Theo ; Schild, Steven E. / A tool to estimate survival of elderly patients presenting with metastatic epidural spinal cord compression (MESCC) from cancer of unknown primary. In: Anticancer Research. 2015 ; Vol. 35, No. 11. pp. 6219-6222.
@article{3c23651638de44f3a14eedd81abb10ca,
title = "A tool to estimate survival of elderly patients presenting with metastatic epidural spinal cord compression (MESCC) from cancer of unknown primary",
abstract = "Aim: Cancers of unknown primary (CUP) account for about 10{\%} in elderly patients with MESCC. Immediate treatment is indicated. Personalizing treatment for MESCC requires for clear understanding of the patients' survival prognosis. In this case, a tool for estimating survival would be valuable. Patients and Methods: In 104 elderly CUP patients, nine factors were investigated: age, gender, performance score, number of affected vertebrae, ability to walk at presentation for radiotherapy, additional bone metastases, visceral metastases, time developing motor weakness, radiotherapy program. Results: In multivariate analysis, the ability to walk (p=0.011) and visceral metastases (p",
keywords = "Cancer of unknown primary, Elderly, MESCC, Radiation therapy, Survival tool",
author = "Dirk Rades and Conde-Moreno, {Antonio J.} and Raquel Garcia and Theo Veninga and Schild, {Steven E.}",
year = "2015",
month = "11",
day = "1",
language = "English (US)",
volume = "35",
pages = "6219--6222",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "11",

}

TY - JOUR

T1 - A tool to estimate survival of elderly patients presenting with metastatic epidural spinal cord compression (MESCC) from cancer of unknown primary

AU - Rades, Dirk

AU - Conde-Moreno, Antonio J.

AU - Garcia, Raquel

AU - Veninga, Theo

AU - Schild, Steven E.

PY - 2015/11/1

Y1 - 2015/11/1

N2 - Aim: Cancers of unknown primary (CUP) account for about 10% in elderly patients with MESCC. Immediate treatment is indicated. Personalizing treatment for MESCC requires for clear understanding of the patients' survival prognosis. In this case, a tool for estimating survival would be valuable. Patients and Methods: In 104 elderly CUP patients, nine factors were investigated: age, gender, performance score, number of affected vertebrae, ability to walk at presentation for radiotherapy, additional bone metastases, visceral metastases, time developing motor weakness, radiotherapy program. Results: In multivariate analysis, the ability to walk (p=0.011) and visceral metastases (p

AB - Aim: Cancers of unknown primary (CUP) account for about 10% in elderly patients with MESCC. Immediate treatment is indicated. Personalizing treatment for MESCC requires for clear understanding of the patients' survival prognosis. In this case, a tool for estimating survival would be valuable. Patients and Methods: In 104 elderly CUP patients, nine factors were investigated: age, gender, performance score, number of affected vertebrae, ability to walk at presentation for radiotherapy, additional bone metastases, visceral metastases, time developing motor weakness, radiotherapy program. Results: In multivariate analysis, the ability to walk (p=0.011) and visceral metastases (p

KW - Cancer of unknown primary

KW - Elderly

KW - MESCC

KW - Radiation therapy

KW - Survival tool

UR - http://www.scopus.com/inward/record.url?scp=84946023770&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946023770&partnerID=8YFLogxK

M3 - Article

C2 - 26504054

AN - SCOPUS:84946023770

VL - 35

SP - 6219

EP - 6222

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 11

ER -